Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, China.
Br J Pharmacol. 2018 Apr;175(8):1230-1240. doi: 10.1111/bph.13814. Epub 2017 May 16.
Adrenomedullin (ADM) 2/intermedin (IMD) is a short peptide that belongs to the CGRP superfamily. Although it shares receptors with CGRP, ADM and amylin, ADM2 has significant and unique functions in the cardiovascular system. In the past decade, the cardiovascular effect of ADM2 has been carefully analysed. In this review, progress in understanding the effects of ADM2 on the cardiovascular system and its protective role in cardiometabolic diseases are summarized.
This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
肾上腺髓质素(ADM)2/中介素(IMD)是一种短肽,属于 CGRP 超家族。虽然它与 CGRP、ADM 和胰淀素共享受体,但 ADM2 在心血管系统中具有重要且独特的功能。在过去的十年中,ADM2 的心血管作用已被仔细分析。在这篇综述中,总结了对 ADM2 对心血管系统的影响及其在心脏代谢疾病中的保护作用的理解进展。
本文是心血管疾病小分子专题的一部分。要查看本节中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.